In a recent statement, President Trump and his health advisor, Robert F. Kennedy Jr., expressed concern regarding the drug tylenol, specifically its potential impact on individuals with autism. The President indicated a perceived urgency in addressing the substance’s effects, prompting questions among those with the condition. Mr. Kennedy Jr. further commented on the potential for tylenol to trigger behavioral issues. While no specific claims were made regarding autism, the remarks generated discussion and raised anxieties amongst those with the condition and their families.
Credits: NYT > Top Stories